Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
9,144
archived clinical trials in
Ocular

Performance Assessment of a Modified Daily Disposable Contact Lens
Performance Assessment of a Modified Daily Disposable Contact Lens
Status: Enrolling
Updated:  12/31/1969
Alcon Investigative Site
mi
from
West Palm Beach, FL
Performance Assessment of a Modified Daily Disposable Contact Lens
Performance Assessment of a Modified Daily Disposable Contact Lens
Status: Enrolling
Updated: 12/31/1969
Alcon Investigative Site
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
Evaluating the Need for the Pseudophakic Intraoperative Abberrometry in Toric IOL Implantation
Evaluating the Need for Pseudophakic Intraoperative Abberrometry in Toric IOL Implantation
Status: Enrolling
Updated:  12/31/1969
Alterman Modi and Wolter Ophthalmic Physicians and Surgeons
mi
from
Poughkeepsie, NY
Evaluating the Need for the Pseudophakic Intraoperative Abberrometry in Toric IOL Implantation
Evaluating the Need for Pseudophakic Intraoperative Abberrometry in Toric IOL Implantation
Status: Enrolling
Updated: 12/31/1969
Alterman Modi and Wolter Ophthalmic Physicians and Surgeons
mi
from
Poughkeepsie, NY
Click here to add this to my saved trials
Efficacy, Safety and PK of Once or Twice Daily Bilastine (10 or 20 mg) Compared With Placebo in the Symptomatic Treatment of SAR
A Multi-Center Randomized, Double-Blind, Placebo-Controlled, Parallel Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Once or Twice Daily Bilastine (10 or 20 mg) Compared With Placebo Given Orally in The Treatment of the Symptoms of Seasonal Allergic Rhino-Conjunctivitis With Allergy to Mountain Cedar Pollen
Status: Enrolling
Updated:  12/31/1969
Oklahoma Allergy and Asthma Clinic
mi
from
Oklahoma City, OK
Efficacy, Safety and PK of Once or Twice Daily Bilastine (10 or 20 mg) Compared With Placebo in the Symptomatic Treatment of SAR
A Multi-Center Randomized, Double-Blind, Placebo-Controlled, Parallel Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Once or Twice Daily Bilastine (10 or 20 mg) Compared With Placebo Given Orally in The Treatment of the Symptoms of Seasonal Allergic Rhino-Conjunctivitis With Allergy to Mountain Cedar Pollen
Status: Enrolling
Updated: 12/31/1969
Oklahoma Allergy and Asthma Clinic
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Efficacy, Safety and PK of Once or Twice Daily Bilastine (10 or 20 mg) Compared With Placebo in the Symptomatic Treatment of SAR
A Multi-Center Randomized, Double-Blind, Placebo-Controlled, Parallel Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Once or Twice Daily Bilastine (10 or 20 mg) Compared With Placebo Given Orally in The Treatment of the Symptoms of Seasonal Allergic Rhino-Conjunctivitis With Allergy to Mountain Cedar Pollen
Status: Enrolling
Updated:  12/31/1969
MetaClin Research, Inc
mi
from
Austin, TX
Efficacy, Safety and PK of Once or Twice Daily Bilastine (10 or 20 mg) Compared With Placebo in the Symptomatic Treatment of SAR
A Multi-Center Randomized, Double-Blind, Placebo-Controlled, Parallel Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Once or Twice Daily Bilastine (10 or 20 mg) Compared With Placebo Given Orally in The Treatment of the Symptoms of Seasonal Allergic Rhino-Conjunctivitis With Allergy to Mountain Cedar Pollen
Status: Enrolling
Updated: 12/31/1969
MetaClin Research, Inc
mi
from
Austin, TX
Click here to add this to my saved trials
Efficacy, Safety and PK of Once or Twice Daily Bilastine (10 or 20 mg) Compared With Placebo in the Symptomatic Treatment of SAR
A Multi-Center Randomized, Double-Blind, Placebo-Controlled, Parallel Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Once or Twice Daily Bilastine (10 or 20 mg) Compared With Placebo Given Orally in The Treatment of the Symptoms of Seasonal Allergic Rhino-Conjunctivitis With Allergy to Mountain Cedar Pollen
Status: Enrolling
Updated:  12/31/1969
Austin Clinical Research
mi
from
Austin, TX
Efficacy, Safety and PK of Once or Twice Daily Bilastine (10 or 20 mg) Compared With Placebo in the Symptomatic Treatment of SAR
A Multi-Center Randomized, Double-Blind, Placebo-Controlled, Parallel Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Once or Twice Daily Bilastine (10 or 20 mg) Compared With Placebo Given Orally in The Treatment of the Symptoms of Seasonal Allergic Rhino-Conjunctivitis With Allergy to Mountain Cedar Pollen
Status: Enrolling
Updated: 12/31/1969
Austin Clinical Research
mi
from
Austin, TX
Click here to add this to my saved trials
Efficacy, Safety and PK of Once or Twice Daily Bilastine (10 or 20 mg) Compared With Placebo in the Symptomatic Treatment of SAR
A Multi-Center Randomized, Double-Blind, Placebo-Controlled, Parallel Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Once or Twice Daily Bilastine (10 or 20 mg) Compared With Placebo Given Orally in The Treatment of the Symptoms of Seasonal Allergic Rhino-Conjunctivitis With Allergy to Mountain Cedar Pollen
Status: Enrolling
Updated:  12/31/1969
Lovelace Scientific Resources
mi
from
Austin, TX
Efficacy, Safety and PK of Once or Twice Daily Bilastine (10 or 20 mg) Compared With Placebo in the Symptomatic Treatment of SAR
A Multi-Center Randomized, Double-Blind, Placebo-Controlled, Parallel Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Once or Twice Daily Bilastine (10 or 20 mg) Compared With Placebo Given Orally in The Treatment of the Symptoms of Seasonal Allergic Rhino-Conjunctivitis With Allergy to Mountain Cedar Pollen
Status: Enrolling
Updated: 12/31/1969
Lovelace Scientific Resources
mi
from
Austin, TX
Click here to add this to my saved trials
Efficacy, Safety and PK of Once or Twice Daily Bilastine (10 or 20 mg) Compared With Placebo in the Symptomatic Treatment of SAR
A Multi-Center Randomized, Double-Blind, Placebo-Controlled, Parallel Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Once or Twice Daily Bilastine (10 or 20 mg) Compared With Placebo Given Orally in The Treatment of the Symptoms of Seasonal Allergic Rhino-Conjunctivitis With Allergy to Mountain Cedar Pollen
Status: Enrolling
Updated:  12/31/1969
Kerrville Research Associates
mi
from
Kerrville, TX
Efficacy, Safety and PK of Once or Twice Daily Bilastine (10 or 20 mg) Compared With Placebo in the Symptomatic Treatment of SAR
A Multi-Center Randomized, Double-Blind, Placebo-Controlled, Parallel Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Once or Twice Daily Bilastine (10 or 20 mg) Compared With Placebo Given Orally in The Treatment of the Symptoms of Seasonal Allergic Rhino-Conjunctivitis With Allergy to Mountain Cedar Pollen
Status: Enrolling
Updated: 12/31/1969
Kerrville Research Associates
mi
from
Kerrville, TX
Click here to add this to my saved trials
Efficacy, Safety and PK of Once or Twice Daily Bilastine (10 or 20 mg) Compared With Placebo in the Symptomatic Treatment of SAR
A Multi-Center Randomized, Double-Blind, Placebo-Controlled, Parallel Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Once or Twice Daily Bilastine (10 or 20 mg) Compared With Placebo Given Orally in The Treatment of the Symptoms of Seasonal Allergic Rhino-Conjunctivitis With Allergy to Mountain Cedar Pollen
Status: Enrolling
Updated:  12/31/1969
Biogenics Research Institute
mi
from
San Antonio, TX
Efficacy, Safety and PK of Once or Twice Daily Bilastine (10 or 20 mg) Compared With Placebo in the Symptomatic Treatment of SAR
A Multi-Center Randomized, Double-Blind, Placebo-Controlled, Parallel Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Once or Twice Daily Bilastine (10 or 20 mg) Compared With Placebo Given Orally in The Treatment of the Symptoms of Seasonal Allergic Rhino-Conjunctivitis With Allergy to Mountain Cedar Pollen
Status: Enrolling
Updated: 12/31/1969
Biogenics Research Institute
mi
from
San Antonio, TX
Click here to add this to my saved trials
Efficacy, Safety and PK of Once or Twice Daily Bilastine (10 or 20 mg) Compared With Placebo in the Symptomatic Treatment of SAR
A Multi-Center Randomized, Double-Blind, Placebo-Controlled, Parallel Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Once or Twice Daily Bilastine (10 or 20 mg) Compared With Placebo Given Orally in The Treatment of the Symptoms of Seasonal Allergic Rhino-Conjunctivitis With Allergy to Mountain Cedar Pollen
Status: Enrolling
Updated:  12/31/1969
dgd Research, Inc.
mi
from
San Antonio, TX
Efficacy, Safety and PK of Once or Twice Daily Bilastine (10 or 20 mg) Compared With Placebo in the Symptomatic Treatment of SAR
A Multi-Center Randomized, Double-Blind, Placebo-Controlled, Parallel Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Once or Twice Daily Bilastine (10 or 20 mg) Compared With Placebo Given Orally in The Treatment of the Symptoms of Seasonal Allergic Rhino-Conjunctivitis With Allergy to Mountain Cedar Pollen
Status: Enrolling
Updated: 12/31/1969
dgd Research, Inc.
mi
from
San Antonio, TX
Click here to add this to my saved trials
Efficacy, Safety and PK of Once or Twice Daily Bilastine (10 or 20 mg) Compared With Placebo in the Symptomatic Treatment of SAR
A Multi-Center Randomized, Double-Blind, Placebo-Controlled, Parallel Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Once or Twice Daily Bilastine (10 or 20 mg) Compared With Placebo Given Orally in The Treatment of the Symptoms of Seasonal Allergic Rhino-Conjunctivitis With Allergy to Mountain Cedar Pollen
Status: Enrolling
Updated:  12/31/1969
Diagnostics Research Group
mi
from
San Antonio, TX
Efficacy, Safety and PK of Once or Twice Daily Bilastine (10 or 20 mg) Compared With Placebo in the Symptomatic Treatment of SAR
A Multi-Center Randomized, Double-Blind, Placebo-Controlled, Parallel Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Once or Twice Daily Bilastine (10 or 20 mg) Compared With Placebo Given Orally in The Treatment of the Symptoms of Seasonal Allergic Rhino-Conjunctivitis With Allergy to Mountain Cedar Pollen
Status: Enrolling
Updated: 12/31/1969
Diagnostics Research Group
mi
from
San Antonio, TX
Click here to add this to my saved trials
Efficacy, Safety and PK of Once or Twice Daily Bilastine (10 or 20 mg) Compared With Placebo in the Symptomatic Treatment of SAR
A Multi-Center Randomized, Double-Blind, Placebo-Controlled, Parallel Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Once or Twice Daily Bilastine (10 or 20 mg) Compared With Placebo Given Orally in The Treatment of the Symptoms of Seasonal Allergic Rhino-Conjunctivitis With Allergy to Mountain Cedar Pollen
Status: Enrolling
Updated:  12/31/1969
Southwest Allergy and Asthma Centre
mi
from
San Antonio, TX
Efficacy, Safety and PK of Once or Twice Daily Bilastine (10 or 20 mg) Compared With Placebo in the Symptomatic Treatment of SAR
A Multi-Center Randomized, Double-Blind, Placebo-Controlled, Parallel Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Once or Twice Daily Bilastine (10 or 20 mg) Compared With Placebo Given Orally in The Treatment of the Symptoms of Seasonal Allergic Rhino-Conjunctivitis With Allergy to Mountain Cedar Pollen
Status: Enrolling
Updated: 12/31/1969
Southwest Allergy and Asthma Centre
mi
from
San Antonio, TX
Click here to add this to my saved trials
Efficacy, Safety and PK of Once or Twice Daily Bilastine (10 or 20 mg) Compared With Placebo in the Symptomatic Treatment of SAR
A Multi-Center Randomized, Double-Blind, Placebo-Controlled, Parallel Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Once or Twice Daily Bilastine (10 or 20 mg) Compared With Placebo Given Orally in The Treatment of the Symptoms of Seasonal Allergic Rhino-Conjunctivitis With Allergy to Mountain Cedar Pollen
Status: Enrolling
Updated:  12/31/1969
Sylvana Research Associates
mi
from
San Antonio, TX
Efficacy, Safety and PK of Once or Twice Daily Bilastine (10 or 20 mg) Compared With Placebo in the Symptomatic Treatment of SAR
A Multi-Center Randomized, Double-Blind, Placebo-Controlled, Parallel Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Once or Twice Daily Bilastine (10 or 20 mg) Compared With Placebo Given Orally in The Treatment of the Symptoms of Seasonal Allergic Rhino-Conjunctivitis With Allergy to Mountain Cedar Pollen
Status: Enrolling
Updated: 12/31/1969
Sylvana Research Associates
mi
from
San Antonio, TX
Click here to add this to my saved trials
Efficacy, Safety and PK of Once or Twice Daily Bilastine (10 or 20 mg) Compared With Placebo in the Symptomatic Treatment of SAR
A Multi-Center Randomized, Double-Blind, Placebo-Controlled, Parallel Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Once or Twice Daily Bilastine (10 or 20 mg) Compared With Placebo Given Orally in The Treatment of the Symptoms of Seasonal Allergic Rhino-Conjunctivitis With Allergy to Mountain Cedar Pollen
Status: Enrolling
Updated:  12/31/1969
Live Oak Allergy and Asthma
mi
from
San Antonio, TX
Efficacy, Safety and PK of Once or Twice Daily Bilastine (10 or 20 mg) Compared With Placebo in the Symptomatic Treatment of SAR
A Multi-Center Randomized, Double-Blind, Placebo-Controlled, Parallel Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Once or Twice Daily Bilastine (10 or 20 mg) Compared With Placebo Given Orally in The Treatment of the Symptoms of Seasonal Allergic Rhino-Conjunctivitis With Allergy to Mountain Cedar Pollen
Status: Enrolling
Updated: 12/31/1969
Live Oak Allergy and Asthma
mi
from
San Antonio, TX
Click here to add this to my saved trials
Efficacy, Safety and PK of Once or Twice Daily Bilastine (10 or 20 mg) Compared With Placebo in the Symptomatic Treatment of SAR
A Multi-Center Randomized, Double-Blind, Placebo-Controlled, Parallel Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Once or Twice Daily Bilastine (10 or 20 mg) Compared With Placebo Given Orally in The Treatment of the Symptoms of Seasonal Allergic Rhino-Conjunctivitis With Allergy to Mountain Cedar Pollen
Status: Enrolling
Updated:  12/31/1969
Allergy & Asthma Care Of Waco
mi
from
Waco, TX
Efficacy, Safety and PK of Once or Twice Daily Bilastine (10 or 20 mg) Compared With Placebo in the Symptomatic Treatment of SAR
A Multi-Center Randomized, Double-Blind, Placebo-Controlled, Parallel Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Once or Twice Daily Bilastine (10 or 20 mg) Compared With Placebo Given Orally in The Treatment of the Symptoms of Seasonal Allergic Rhino-Conjunctivitis With Allergy to Mountain Cedar Pollen
Status: Enrolling
Updated: 12/31/1969
Allergy & Asthma Care Of Waco
mi
from
Waco, TX
Click here to add this to my saved trials
Efficacy, Safety and PK of Once or Twice Daily Bilastine (10 or 20 mg) Compared With Placebo in the Symptomatic Treatment of SAR
A Multi-Center Randomized, Double-Blind, Placebo-Controlled, Parallel Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Once or Twice Daily Bilastine (10 or 20 mg) Compared With Placebo Given Orally in The Treatment of the Symptoms of Seasonal Allergic Rhino-Conjunctivitis With Allergy to Mountain Cedar Pollen
Status: Enrolling
Updated:  12/31/1969
Allergy and Asthma Research Institute
mi
from
Waco, TX
Efficacy, Safety and PK of Once or Twice Daily Bilastine (10 or 20 mg) Compared With Placebo in the Symptomatic Treatment of SAR
A Multi-Center Randomized, Double-Blind, Placebo-Controlled, Parallel Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Once or Twice Daily Bilastine (10 or 20 mg) Compared With Placebo Given Orally in The Treatment of the Symptoms of Seasonal Allergic Rhino-Conjunctivitis With Allergy to Mountain Cedar Pollen
Status: Enrolling
Updated: 12/31/1969
Allergy and Asthma Research Institute
mi
from
Waco, TX
Click here to add this to my saved trials
An Open-Label Extension Study to Evaluate the Safety of the ForSight VISION5 Product
An Open-Label Extension (OLE) Study to Evaluate the Safety of the ForSight VISION5 Product in Subjects With Open-Angle Glaucoma or Ocular Hypertension Who Have Completed Study FSV5-002
Status: Enrolling
Updated:  12/31/1969
Sall Medical Research Center
mi
from
Artesia, CA
An Open-Label Extension Study to Evaluate the Safety of the ForSight VISION5 Product
An Open-Label Extension (OLE) Study to Evaluate the Safety of the ForSight VISION5 Product in Subjects With Open-Angle Glaucoma or Ocular Hypertension Who Have Completed Study FSV5-002
Status: Enrolling
Updated: 12/31/1969
Sall Medical Research Center
mi
from
Artesia, CA
Click here to add this to my saved trials
An Open-Label Extension Study to Evaluate the Safety of the ForSight VISION5 Product
An Open-Label Extension (OLE) Study to Evaluate the Safety of the ForSight VISION5 Product in Subjects With Open-Angle Glaucoma or Ocular Hypertension Who Have Completed Study FSV5-002
Status: Enrolling
Updated:  12/31/1969
Scripps Clinic at Torrey Pines
mi
from
La Jolla, CA
An Open-Label Extension Study to Evaluate the Safety of the ForSight VISION5 Product
An Open-Label Extension (OLE) Study to Evaluate the Safety of the ForSight VISION5 Product in Subjects With Open-Angle Glaucoma or Ocular Hypertension Who Have Completed Study FSV5-002
Status: Enrolling
Updated: 12/31/1969
Scripps Clinic at Torrey Pines
mi
from
La Jolla, CA
Click here to add this to my saved trials
An Open-Label Extension Study to Evaluate the Safety of the ForSight VISION5 Product
An Open-Label Extension (OLE) Study to Evaluate the Safety of the ForSight VISION5 Product in Subjects With Open-Angle Glaucoma or Ocular Hypertension Who Have Completed Study FSV5-002
Status: Enrolling
Updated:  12/31/1969
Eye Research Foundation
mi
from
Newport Beach, CA
An Open-Label Extension Study to Evaluate the Safety of the ForSight VISION5 Product
An Open-Label Extension (OLE) Study to Evaluate the Safety of the ForSight VISION5 Product in Subjects With Open-Angle Glaucoma or Ocular Hypertension Who Have Completed Study FSV5-002
Status: Enrolling
Updated: 12/31/1969
Eye Research Foundation
mi
from
Newport Beach, CA
Click here to add this to my saved trials
An Open-Label Extension Study to Evaluate the Safety of the ForSight VISION5 Product
An Open-Label Extension (OLE) Study to Evaluate the Safety of the ForSight VISION5 Product in Subjects With Open-Angle Glaucoma or Ocular Hypertension Who Have Completed Study FSV5-002
Status: Enrolling
Updated:  12/31/1969
UC Davis Dept of Ophthalmology & Vision Science
mi
from
Sacramento, CA
An Open-Label Extension Study to Evaluate the Safety of the ForSight VISION5 Product
An Open-Label Extension (OLE) Study to Evaluate the Safety of the ForSight VISION5 Product in Subjects With Open-Angle Glaucoma or Ocular Hypertension Who Have Completed Study FSV5-002
Status: Enrolling
Updated: 12/31/1969
UC Davis Dept of Ophthalmology & Vision Science
mi
from
Sacramento, CA
Click here to add this to my saved trials
An Open-Label Extension Study to Evaluate the Safety of the ForSight VISION5 Product
An Open-Label Extension (OLE) Study to Evaluate the Safety of the ForSight VISION5 Product in Subjects With Open-Angle Glaucoma or Ocular Hypertension Who Have Completed Study FSV5-002
Status: Enrolling
Updated:  12/31/1969
Coastal Research Associates, LLC
mi
from
Atlanta, GA
An Open-Label Extension Study to Evaluate the Safety of the ForSight VISION5 Product
An Open-Label Extension (OLE) Study to Evaluate the Safety of the ForSight VISION5 Product in Subjects With Open-Angle Glaucoma or Ocular Hypertension Who Have Completed Study FSV5-002
Status: Enrolling
Updated: 12/31/1969
Coastal Research Associates, LLC
mi
from
Atlanta, GA
Click here to add this to my saved trials
An Open-Label Extension Study to Evaluate the Safety of the ForSight VISION5 Product
An Open-Label Extension (OLE) Study to Evaluate the Safety of the ForSight VISION5 Product in Subjects With Open-Angle Glaucoma or Ocular Hypertension Who Have Completed Study FSV5-002
Status: Enrolling
Updated:  12/31/1969
Clayton Eye Center
mi
from
Morrow, GA
An Open-Label Extension Study to Evaluate the Safety of the ForSight VISION5 Product
An Open-Label Extension (OLE) Study to Evaluate the Safety of the ForSight VISION5 Product in Subjects With Open-Angle Glaucoma or Ocular Hypertension Who Have Completed Study FSV5-002
Status: Enrolling
Updated: 12/31/1969
Clayton Eye Center
mi
from
Morrow, GA
Click here to add this to my saved trials
An Open-Label Extension Study to Evaluate the Safety of the ForSight VISION5 Product
An Open-Label Extension (OLE) Study to Evaluate the Safety of the ForSight VISION5 Product in Subjects With Open-Angle Glaucoma or Ocular Hypertension Who Have Completed Study FSV5-002
Status: Enrolling
Updated:  12/31/1969
Ophthalmology Consultants Ltd
mi
from
Saint Louis, MO
An Open-Label Extension Study to Evaluate the Safety of the ForSight VISION5 Product
An Open-Label Extension (OLE) Study to Evaluate the Safety of the ForSight VISION5 Product in Subjects With Open-Angle Glaucoma or Ocular Hypertension Who Have Completed Study FSV5-002
Status: Enrolling
Updated: 12/31/1969
Ophthalmology Consultants Ltd
mi
from
Saint Louis, MO
Click here to add this to my saved trials
An Open-Label Extension Study to Evaluate the Safety of the ForSight VISION5 Product
An Open-Label Extension (OLE) Study to Evaluate the Safety of the ForSight VISION5 Product in Subjects With Open-Angle Glaucoma or Ocular Hypertension Who Have Completed Study FSV5-002
Status: Enrolling
Updated:  12/31/1969
UNC Kittner Eye Center
mi
from
Chapel Hill, NC
An Open-Label Extension Study to Evaluate the Safety of the ForSight VISION5 Product
An Open-Label Extension (OLE) Study to Evaluate the Safety of the ForSight VISION5 Product in Subjects With Open-Angle Glaucoma or Ocular Hypertension Who Have Completed Study FSV5-002
Status: Enrolling
Updated: 12/31/1969
UNC Kittner Eye Center
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
An Open-Label Extension Study to Evaluate the Safety of the ForSight VISION5 Product
An Open-Label Extension (OLE) Study to Evaluate the Safety of the ForSight VISION5 Product in Subjects With Open-Angle Glaucoma or Ocular Hypertension Who Have Completed Study FSV5-002
Status: Enrolling
Updated:  12/31/1969
Apex Eye
mi
from
Madeira, OH
An Open-Label Extension Study to Evaluate the Safety of the ForSight VISION5 Product
An Open-Label Extension (OLE) Study to Evaluate the Safety of the ForSight VISION5 Product in Subjects With Open-Angle Glaucoma or Ocular Hypertension Who Have Completed Study FSV5-002
Status: Enrolling
Updated: 12/31/1969
Apex Eye
mi
from
Madeira, OH
Click here to add this to my saved trials
An Open-Label Extension Study to Evaluate the Safety of the ForSight VISION5 Product
An Open-Label Extension (OLE) Study to Evaluate the Safety of the ForSight VISION5 Product in Subjects With Open-Angle Glaucoma or Ocular Hypertension Who Have Completed Study FSV5-002
Status: Enrolling
Updated:  12/31/1969
Ophthalmology Associates
mi
from
Fort Worth, TX
An Open-Label Extension Study to Evaluate the Safety of the ForSight VISION5 Product
An Open-Label Extension (OLE) Study to Evaluate the Safety of the ForSight VISION5 Product in Subjects With Open-Angle Glaucoma or Ocular Hypertension Who Have Completed Study FSV5-002
Status: Enrolling
Updated: 12/31/1969
Ophthalmology Associates
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Assessing Ocular Hemodynamic Response to Surgical Intervention in Glaucoma
Assessing Ocular Hemodynamic Response to Surgical Intervention in Glaucoma
Status: Enrolling
Updated:  12/31/1969
UNC Kittner Eye Center
mi
from
Chapel Hill, NC
Assessing Ocular Hemodynamic Response to Surgical Intervention in Glaucoma
Assessing Ocular Hemodynamic Response to Surgical Intervention in Glaucoma
Status: Enrolling
Updated: 12/31/1969
UNC Kittner Eye Center
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Chart Review: Drug Utilization Study in Participants Who Received Ozurdex™ (Dexamethasone Intravitreal Implant) 0.7 mg Injections for Visual Impairment Due to Diabetic Macular Edema (DME)
Drug Utilization Study in Patients Receiving Ozurdex™ (Dexamethasone Intravitreal Implant) 0.7 mg Injections for Visual Impairment Due to Diabetic Macular Edema (DME)
Status: Enrolling
Updated:  12/31/1969
Clinical Trials Registry Team
mi
from
Irvine, CA
Chart Review: Drug Utilization Study in Participants Who Received Ozurdex™ (Dexamethasone Intravitreal Implant) 0.7 mg Injections for Visual Impairment Due to Diabetic Macular Edema (DME)
Drug Utilization Study in Patients Receiving Ozurdex™ (Dexamethasone Intravitreal Implant) 0.7 mg Injections for Visual Impairment Due to Diabetic Macular Edema (DME)
Status: Enrolling
Updated: 12/31/1969
Clinical Trials Registry Team
mi
from
Irvine, CA
Click here to add this to my saved trials
Ultrasound to Detect Evidence for Retinal Detachment in Retinopathy of Prematurity
Ultrasound to Detect Evidence for Retinal Detachment in Retinopathy of Prematurity
Status: Enrolling
Updated:  12/31/1969
Columbia Presbyterian Med Ctr
mi
from
New York, NY
Ultrasound to Detect Evidence for Retinal Detachment in Retinopathy of Prematurity
Ultrasound to Detect Evidence for Retinal Detachment in Retinopathy of Prematurity
Status: Enrolling
Updated: 12/31/1969
Columbia Presbyterian Med Ctr
mi
from
New York, NY
Click here to add this to my saved trials
Therapeutic Equivalence Study of Generic Brinzolamide vs Azopt
A BIOEQUIVALENCE STUDY OF THE GENERIC BRINZOLAMIDE 1% OPHTHALMIC SUSPENSION COMPARED TO REFERENCE LISTED DRUG AZOPT® (BRINZOLAMIDE) OPHTHALMIC SUSPENSION 1% IN SUBJECTS WITH PRIMARY OPEN ANGLE GLAUCOMA OR OCULAR HYPERTENSION
Status: Enrolling
Updated:  12/31/1969
Various
mi
from
Bridgewater, NJ
Therapeutic Equivalence Study of Generic Brinzolamide vs Azopt
A BIOEQUIVALENCE STUDY OF THE GENERIC BRINZOLAMIDE 1% OPHTHALMIC SUSPENSION COMPARED TO REFERENCE LISTED DRUG AZOPT® (BRINZOLAMIDE) OPHTHALMIC SUSPENSION 1% IN SUBJECTS WITH PRIMARY OPEN ANGLE GLAUCOMA OR OCULAR HYPERTENSION
Status: Enrolling
Updated: 12/31/1969
Various
mi
from
Bridgewater, NJ
Click here to add this to my saved trials
A Safety and Efficacy Study of Carbidopa-levodopa in Patients With Macular Degeneration
Pilot Study of L-DOPA Safety and Tolerability in Patients With AMD, and Proof of Concept That L-DOPA Improves Surrogate Biomarkers in Patients With Moderate to Advanced AMD
Status: Enrolling
Updated:  12/31/1969
Robert W Snyder, MD, PhD, PC
mi
from
Tucson, AZ
A Safety and Efficacy Study of Carbidopa-levodopa in Patients With Macular Degeneration
Pilot Study of L-DOPA Safety and Tolerability in Patients With AMD, and Proof of Concept That L-DOPA Improves Surrogate Biomarkers in Patients With Moderate to Advanced AMD
Status: Enrolling
Updated: 12/31/1969
Robert W Snyder, MD, PhD, PC
mi
from
Tucson, AZ
Click here to add this to my saved trials
Study of Dehydrex in Patients With Corneal Erosion
Topical Dehydrex in Treating Recurrent Corneal Erosion
Status: Enrolling
Updated:  6/23/2005
Holles Laboratories, Inc.
mi
from
Cohasset, MA
Study of Dehydrex in Patients With Corneal Erosion
Topical Dehydrex in Treating Recurrent Corneal Erosion
Status: Enrolling
Updated: 6/23/2005
Holles Laboratories, Inc.
mi
from
Cohasset, MA
Click here to add this to my saved trials
PST/Laser v. Laser Alone for CSME
Combined Posterior Sub-Tenon Injection of Triamcinolone Acetonide and Laser Photocoagulation for the Treatment of Clinically Significant Macular Edema
Status: Enrolling
Updated:  9/28/2005
Edward Hines Jr. VAH
mi
from
Hines, IL
PST/Laser v. Laser Alone for CSME
Combined Posterior Sub-Tenon Injection of Triamcinolone Acetonide and Laser Photocoagulation for the Treatment of Clinically Significant Macular Edema
Status: Enrolling
Updated: 9/28/2005
Edward Hines Jr. VAH
mi
from
Hines, IL
Click here to add this to my saved trials
Quality of Life and Visual Function in Uveitis Patients
Status: Enrolling
Updated:  12/4/2006
New York Eye & Ear Infirmary
mi
from
New York, NY
Quality of Life and Visual Function in Uveitis Patients
Status: Enrolling
Updated: 12/4/2006
New York Eye & Ear Infirmary
mi
from
New York, NY
Click here to add this to my saved trials
Analysis of Human Tear Proteins in Children
Analysis of Human Tear Proteins in Children: A Pilot Study to Describe the Tear Film Proteome of Pediatric Patients Undergoing Ophthalmic Examination.
Status: Enrolling
Updated:  5/11/2007
The Children's Hospital
mi
from
Denver, CO
Analysis of Human Tear Proteins in Children
Analysis of Human Tear Proteins in Children: A Pilot Study to Describe the Tear Film Proteome of Pediatric Patients Undergoing Ophthalmic Examination.
Status: Enrolling
Updated: 5/11/2007
The Children's Hospital
mi
from
Denver, CO
Click here to add this to my saved trials
Treatment of Exudative and Vasogenic Chorioretinal Diseases Including Variants of Age-Related Macular Degeneration (AMD) and Other Related Maculopathy
Treatment of Exudative and Vasogenic Chorioretinal Diseases Including Variants of AMD and Other CNV Related Maculopathy (Coats’ Disease, Idiopathic Perifoveal Telangiectasia, Retinal Angiomatous Proliferation, Polypoidal Vasculopathy, Pseudoxanthoma Elasticum, Pathological Myopia, Multi-Focal Choroiditis, Rubeosis Iridis) With Intravitreal Injection of Lucentis (Ranibizumab Injection)
Status: Enrolling
Updated:  7/18/2007
Vitreous-Retina-Macula Consultants of New York
mi
from
New York, NY
Treatment of Exudative and Vasogenic Chorioretinal Diseases Including Variants of Age-Related Macular Degeneration (AMD) and Other Related Maculopathy
Treatment of Exudative and Vasogenic Chorioretinal Diseases Including Variants of AMD and Other CNV Related Maculopathy (Coats’ Disease, Idiopathic Perifoveal Telangiectasia, Retinal Angiomatous Proliferation, Polypoidal Vasculopathy, Pseudoxanthoma Elasticum, Pathological Myopia, Multi-Focal Choroiditis, Rubeosis Iridis) With Intravitreal Injection of Lucentis (Ranibizumab Injection)
Status: Enrolling
Updated: 7/18/2007
Vitreous-Retina-Macula Consultants of New York
mi
from
New York, NY
Click here to add this to my saved trials
Treatment of Exudative and Vasogenic Chorioretinal Diseases Including Variants of Age-Related Macular Degeneration (AMD) and Other Related Maculopathy
Treatment of Exudative and Vasogenic Chorioretinal Diseases Including Variants of AMD and Other CNV Related Maculopathy (Coats’ Disease, Idiopathic Perifoveal Telangiectasia, Retinal Angiomatous Proliferation, Polypoidal Vasculopathy, Pseudoxanthoma Elasticum, Pathological Myopia, Multi-Focal Choroiditis, Rubeosis Iridis) With Intravitreal Injection of Lucentis (Ranibizumab Injection)
Status: Enrolling
Updated:  7/18/2007
Manhattan Eye, Ear & Throat Hospital
mi
from
New York, NY
Treatment of Exudative and Vasogenic Chorioretinal Diseases Including Variants of Age-Related Macular Degeneration (AMD) and Other Related Maculopathy
Treatment of Exudative and Vasogenic Chorioretinal Diseases Including Variants of AMD and Other CNV Related Maculopathy (Coats’ Disease, Idiopathic Perifoveal Telangiectasia, Retinal Angiomatous Proliferation, Polypoidal Vasculopathy, Pseudoxanthoma Elasticum, Pathological Myopia, Multi-Focal Choroiditis, Rubeosis Iridis) With Intravitreal Injection of Lucentis (Ranibizumab Injection)
Status: Enrolling
Updated: 7/18/2007
Manhattan Eye, Ear & Throat Hospital
mi
from
New York, NY
Click here to add this to my saved trials
Evaluation of Ranibizumab in Proliferative Diabetic Retinopathy (PDR) Requiring Vitrectomy
Evaluation of Ranibizumab on the Ease of Procedure and Complication Rate in Proliferative Diabetic Retinopathy (PDR) Requiring Vitrectomy
Status: Enrolling
Updated:  8/14/2007
Retina Associates, PA
mi
from
Shawnee Mission, KA
Evaluation of Ranibizumab in Proliferative Diabetic Retinopathy (PDR) Requiring Vitrectomy
Evaluation of Ranibizumab on the Ease of Procedure and Complication Rate in Proliferative Diabetic Retinopathy (PDR) Requiring Vitrectomy
Status: Enrolling
Updated: 8/14/2007
Retina Associates, PA
mi
from
Shawnee Mission, KA
Click here to add this to my saved trials
Evaluation of Corneal Staining With Various Contact Lens/Solution Combinations
Evaluation of Corneal Staining With Market Contact Lens/Solution Combinations
Status: Enrolling
Updated:  9/26/2007
Dr. Richard Erdey office
mi
from
Columbus, OH
Evaluation of Corneal Staining With Various Contact Lens/Solution Combinations
Evaluation of Corneal Staining With Market Contact Lens/Solution Combinations
Status: Enrolling
Updated: 9/26/2007
Dr. Richard Erdey office
mi
from
Columbus, OH
Click here to add this to my saved trials
Comparison of the Alpha-2 Agonists for Prevention of Intraocular Pressure Elevation After Selective Laser Trabeculoplasty
Comparison of the Alpha-2 Agonists for Prevention of Intraocular Pressure Elevation After Selective Laser Trabeculoplasty
Status: Enrolling
Updated:  12/4/2007
Walter Reed Army Medical Center
mi
from
Washington,
Comparison of the Alpha-2 Agonists for Prevention of Intraocular Pressure Elevation After Selective Laser Trabeculoplasty
Comparison of the Alpha-2 Agonists for Prevention of Intraocular Pressure Elevation After Selective Laser Trabeculoplasty
Status: Enrolling
Updated: 12/4/2007
Walter Reed Army Medical Center
mi
from
Washington,
Click here to add this to my saved trials
Evaluation of the Bausch & Lomb PureVision Under Nighttime Driving Conditions
Evaluation of the Bausch & Lomb PureVision Under Nighttime Driving Conditions
Status: Enrolling
Updated:  12/19/2007
National Advanced Driving Simulator
mi
from
Iowa City, IA
Evaluation of the Bausch & Lomb PureVision Under Nighttime Driving Conditions
Evaluation of the Bausch & Lomb PureVision Under Nighttime Driving Conditions
Status: Enrolling
Updated: 12/19/2007
National Advanced Driving Simulator
mi
from
Iowa City, IA
Click here to add this to my saved trials
Effect of Age on Latanoprost 0.005% in Patients With Glaucoma
Effect of Age on Efficacy and Response Time of Latanoprost 0.005% in Patients With Glaucoma
Status: Enrolling
Updated:  2/21/2008
Yale Eye Center
mi
from
New Haven, CT
Effect of Age on Latanoprost 0.005% in Patients With Glaucoma
Effect of Age on Efficacy and Response Time of Latanoprost 0.005% in Patients With Glaucoma
Status: Enrolling
Updated: 2/21/2008
Yale Eye Center
mi
from
New Haven, CT
Click here to add this to my saved trials
Topical Ocular Mecamylamine in Diabetic Macular Edema (DME)
Phase 2 Study of the Safety and Bioactivity of Topical Ocular Mecamylamine for the Treatment of Diabetic Macular Edema (DME)
Status: Enrolling
Updated:  4/3/2008
East Bay Retina Consultants, Inc.
mi
from
Oakland, CA
Topical Ocular Mecamylamine in Diabetic Macular Edema (DME)
Phase 2 Study of the Safety and Bioactivity of Topical Ocular Mecamylamine for the Treatment of Diabetic Macular Edema (DME)
Status: Enrolling
Updated: 4/3/2008
East Bay Retina Consultants, Inc.
mi
from
Oakland, CA
Click here to add this to my saved trials
Topical Ocular Mecamylamine in Diabetic Macular Edema (DME)
Phase 2 Study of the Safety and Bioactivity of Topical Ocular Mecamylamine for the Treatment of Diabetic Macular Edema (DME)
Status: Enrolling
Updated:  4/3/2008
Johns Hopkins School of Medicine / Wilmer Eye Institute
mi
from
Baltimore, MD
Topical Ocular Mecamylamine in Diabetic Macular Edema (DME)
Phase 2 Study of the Safety and Bioactivity of Topical Ocular Mecamylamine for the Treatment of Diabetic Macular Edema (DME)
Status: Enrolling
Updated: 4/3/2008
Johns Hopkins School of Medicine / Wilmer Eye Institute
mi
from
Baltimore, MD
Click here to add this to my saved trials
Topical Ocular Mecamylamine in Diabetic Macular Edema (DME)
Phase 2 Study of the Safety and Bioactivity of Topical Ocular Mecamylamine for the Treatment of Diabetic Macular Edema (DME)
Status: Enrolling
Updated:  4/3/2008
Ophthalmic Consultants of Boston
mi
from
Boston, MA
Topical Ocular Mecamylamine in Diabetic Macular Edema (DME)
Phase 2 Study of the Safety and Bioactivity of Topical Ocular Mecamylamine for the Treatment of Diabetic Macular Edema (DME)
Status: Enrolling
Updated: 4/3/2008
Ophthalmic Consultants of Boston
mi
from
Boston, MA
Click here to add this to my saved trials
Dietary Lutein and the Retinopathy of Prematurity
The Placental and Mammary Transfer of Lutein and Zeaxanthin Into the Fetus and the Breast-Fed Infant
Status: Enrolling
Updated:  5/5/2008
Oregon Health and Science University
mi
from
Portland, OR
Dietary Lutein and the Retinopathy of Prematurity
The Placental and Mammary Transfer of Lutein and Zeaxanthin Into the Fetus and the Breast-Fed Infant
Status: Enrolling
Updated: 5/5/2008
Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
Comparison of Scheimpflug Photos of the Crystalline Lens in Patients Who Have Undergone Vitrectomy Surgery and Controls
Comparison of Scheimpflug Photos of the Crystalline Lens in Patients Who Have Undergone Vitrectony Surgery and Controls
Status: Enrolling
Updated:  5/6/2008
Barnes Retina Institute
mi
from
St. Louis, MO
Comparison of Scheimpflug Photos of the Crystalline Lens in Patients Who Have Undergone Vitrectomy Surgery and Controls
Comparison of Scheimpflug Photos of the Crystalline Lens in Patients Who Have Undergone Vitrectony Surgery and Controls
Status: Enrolling
Updated: 5/6/2008
Barnes Retina Institute
mi
from
St. Louis, MO
Click here to add this to my saved trials
Intraocular Pressure Accuracy and Variability of the Barraquer Tonometer
Study to Compare the Accuracy and Variability of the Barraquer Tonometer With Other Methods of Tonometry
Status: Enrolling
Updated:  5/6/2008
Washington University School of Medicine and Barnes Jewish Hospital
mi
from
St. Louis, MO
Intraocular Pressure Accuracy and Variability of the Barraquer Tonometer
Study to Compare the Accuracy and Variability of the Barraquer Tonometer With Other Methods of Tonometry
Status: Enrolling
Updated: 5/6/2008
Washington University School of Medicine and Barnes Jewish Hospital
mi
from
St. Louis, MO
Click here to add this to my saved trials
Study of Treatment Effects of Combination Therapy of Lucentis Plus Reduced Fluence PDT With Visudyne in Patients With Exudative AMD
An Open-Label, Single-Site, Comparative, Pilot Study of the Treatment Effects of Combination Therapy of Lucentis (Ranibizumab) Plus Reduced Fluence Photodynamic Therapy With Visudyne in Patients With Exudative Age-Related Macular Degeneration (AMD)
Status: Enrolling
Updated:  5/6/2008
Barnes Retina Institute
mi
from
St. Louis, MO
Study of Treatment Effects of Combination Therapy of Lucentis Plus Reduced Fluence PDT With Visudyne in Patients With Exudative AMD
An Open-Label, Single-Site, Comparative, Pilot Study of the Treatment Effects of Combination Therapy of Lucentis (Ranibizumab) Plus Reduced Fluence Photodynamic Therapy With Visudyne in Patients With Exudative Age-Related Macular Degeneration (AMD)
Status: Enrolling
Updated: 5/6/2008
Barnes Retina Institute
mi
from
St. Louis, MO
Click here to add this to my saved trials
Early Experience With Descemet's Stripping Automated Endothelial Keratoplasty
Early Experience With Descemet's Stripping Automated Endothelial Keratoplasty (DSAEK) in Patients With Corneal Endothelial Cell Dysfunction: Clinical Outcomes and Diagnostic Imaging Analysis
Status: Enrolling
Updated:  8/29/2008
UTSW Medical Center at Dalla - Aston Ambulatory Clinic
mi
from
Dallas, TX
Early Experience With Descemet's Stripping Automated Endothelial Keratoplasty
Early Experience With Descemet's Stripping Automated Endothelial Keratoplasty (DSAEK) in Patients With Corneal Endothelial Cell Dysfunction: Clinical Outcomes and Diagnostic Imaging Analysis
Status: Enrolling
Updated: 8/29/2008
UTSW Medical Center at Dalla - Aston Ambulatory Clinic
mi
from
Dallas, TX
Click here to add this to my saved trials
Observational Study of How Patients Take Eye Drops
The Relationship Between Glaucoma Medication Self-Efficacy, Outcome Expectations, Eye Drop Tech., Adherence and IOP.
Status: Enrolling
Updated:  9/9/2008
Glaucoma Specialists
mi
from
Baltimore, MD
Observational Study of How Patients Take Eye Drops
The Relationship Between Glaucoma Medication Self-Efficacy, Outcome Expectations, Eye Drop Tech., Adherence and IOP.
Status: Enrolling
Updated: 9/9/2008
Glaucoma Specialists
mi
from
Baltimore, MD
Click here to add this to my saved trials